Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00800904

NIS-RTH-DUM-2008/1

Details and patient eligibility

About

The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.

Enrollment: 1,210 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Established persistent asthma
• Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer

Exclusion criteria

• Currently participating or have participated in a study with an investigational compound within the last 30 days
• Current diagnosis of chronic obstructive pulmonary disease (COPD)
• Smoked more than 10 packs a year